Viking Therapeutics, Inc. Cash Flow Statement

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -23.54M-12.09M-13.87M-19.07M-22.93M-25.64M-39.43M-54.98M-68.77M-85.81M-109.98M
Share-based Compensation 0.01M2.60M1.79M1.45M2.61M3.74M5.82M6.10M8.67M16.75M29.71M
Gains from Sales and Divestitures 0.70M0.29M0.06M0.06M0.06M0.13M0.27M0.41M0.79M1.55M
Gains from Investment Securities 0.37M0.88M1.58M2.01M2.58M3.37M4.09M5.16M5.25M4.73M
Non-cash Items 0.59M0.83M1.22M1.79M2.25M2.96M2.47M141.30M
Cash from Operations -1.59M-8.73M-11.07M-14.76M-18.75M-24.75M-21.78M-47.59M-48.40M-73.38M-87.79M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.56M0.89M1.79M1.28M0.40M0.48M3.81M-3.91M-1.22M8.20M17.27M
Amortization of Deferred Charges 0.26M0.28M0.30M
Change in Working Capital
Change in Account Payables 0.19M0.22M0.68M0.26M-0.51M1.47M1.55M-2.54M7.08M-1.02M2.30M
Change in Accured Expenses 0.08M1.56M-0.14M1.01M1.47M0.42M3.77M-0.51M5.81M-1.82M5.82M
Investing Activities
Change in Acquisitions & Divestments 2.56M19.95M20.80M82.47M369.87M322.20M205.97M176.18M299.22M560.00M
Cash from Investing Activities -13.47M3.03M-1.73M-265.73M7.46M41.57M37.96M54.75M-179.09M-553.37M
Financing Activities
Other financing activities 0.33M2.78M1.10M0.50M0.77M0.07M0.03M0.05M0.02M
Debt Issuance and Repayment
Long-Term Debt Issuances 2.50M
Long-Term Debt Repayments 0.09M0.08M3.83M
Change in Capital Stock
Shares Issued 25.39M11.55M22.35M296.61M7.63M0.85M6.77M10.81M
Shares Repurchased 0.00M0.00M0.00M6.79M
Misc.
Cash from Financing Activities 2.17M22.21M10.35M22.40M300.27M0.89M0.95M6.88M4.16M271.38M612.46M
Exchange Rate Effect -0.26M-0.03M-0.15M
Change in Cash 0.58M0.01M2.31M5.91M15.79M-16.40M20.74M-2.75M10.52M18.91M-28.69M
Free Cash Flow -1.59M-8.73M-11.07M-14.76M-18.75M-24.75M-21.78M-47.59M-48.40M-73.38M-87.79M
Net Cash Flow 0.58M0.01M2.31M5.91M15.79M-16.40M20.74M-2.75M10.52M18.91M-28.69M